×
Business

Retrophin, Founded by Martin Shkreli, Rebrands Itself as Travere Therapeutics

Published Nov 16 2020 at 1:00 PM GMT
WSJ

WSJ / Wall Street Journal @wsj.com

Continue reading at wsj.com
Key
Points
  • The biopharmaceutical company will begin trading under the new name and ticker on Thursday.
Credit
Tags
Continue reading at wsj.com
Trending

Stats

  • Published Nov 16, 2020 1:00 PM GMT